Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025442007> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2025442007 endingPage "900" @default.
- W2025442007 startingPage "891" @default.
- W2025442007 abstract "The efficacy and tolerability of gabapentin therapy for seizures in patients in clinical practice were retrospectively evaluated. Demographics, seizure type and history, prior anticonvulsant therapy, concomitant anticonvulsant medications, gabapentin dosing, side effects, seizure response, and tolerability data were obtained from 100 consecutive clinical practice patients (47 men and 53 women) treated with gabapentin. All patients had been previously treated with a mean of 2.9 anticonvulsant drugs and were currently taking a mean of 1.75 anticonvulsant drugs. Seventy-two patients experienced a greater than 50% reduction in seizures, and 23 of these patients experienced a greater than 75% reduction; 57 patients continued gabapentin treatment, 5 of whom remain seizure free and side effect free with gabapentin monotherapy. Of the 42 patients discontinuing treatment, 17 had no seizure reduction, 17 had side effects, and 8 had both. One additional patient died. The mean daily dosage for all 100 patients was 2107 mg, and the mean daily dosage for patients who continued gabapentin treatment was 2270 mg. No linear relationship was found between dosage and patient weight. Fifty-two patients had the dosage of at least 1 concomitant anticonvulsant medication reduced, 31 had at least 1 concomitant anticonvulsant medication removed from the regimen, and 9 required a dosage increase of at least 1 anticonvulsant medication. Twenty patients experienced fatigue, which was usually transient after treatment initiation; in 13 patients fatigue was associated with carbamazepine therapy. In addition, 7 patients experienced ataxia (6 of whom were taking concomitant carbamazepine), and 2 experienced weight gain. Patients experiencing side effects resulting in discontinuation were taking a mean daily dose of gabapentin of 1182 mg. The maximum effective and tolerable daily dosage under clinical practice conditions appears to exceed dosages established in clinical trials. The results of our study suggest broader treatment parameters for gabapentin than initially determined in the more restrictive clinical trials conducted during the drug's development." @default.
- W2025442007 created "2016-06-24" @default.
- W2025442007 creator A5005261724 @default.
- W2025442007 date "1995-10-01" @default.
- W2025442007 modified "2023-10-06" @default.
- W2025442007 title "Efficacy and tolerability of gabapentin in clinical practice" @default.
- W2025442007 cites W1995716893 @default.
- W2025442007 cites W1997955014 @default.
- W2025442007 cites W2142490371 @default.
- W2025442007 cites W2154041886 @default.
- W2025442007 cites W2268255412 @default.
- W2025442007 cites W2320058521 @default.
- W2025442007 cites W2322086287 @default.
- W2025442007 cites W2588572157 @default.
- W2025442007 cites W2496442096 @default.
- W2025442007 doi "https://doi.org/10.1016/0149-2918(95)80067-0" @default.
- W2025442007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8595641" @default.
- W2025442007 hasPublicationYear "1995" @default.
- W2025442007 type Work @default.
- W2025442007 sameAs 2025442007 @default.
- W2025442007 citedByCount "24" @default.
- W2025442007 countsByYear W20254420072012 @default.
- W2025442007 countsByYear W20254420072013 @default.
- W2025442007 countsByYear W20254420072014 @default.
- W2025442007 countsByYear W20254420072022 @default.
- W2025442007 countsByYear W20254420072023 @default.
- W2025442007 crossrefType "journal-article" @default.
- W2025442007 hasAuthorship W2025442007A5005261724 @default.
- W2025442007 hasConcept C118552586 @default.
- W2025442007 hasConcept C126322002 @default.
- W2025442007 hasConcept C142724271 @default.
- W2025442007 hasConcept C197934379 @default.
- W2025442007 hasConcept C204787440 @default.
- W2025442007 hasConcept C2775858608 @default.
- W2025442007 hasConcept C2776608144 @default.
- W2025442007 hasConcept C2777288759 @default.
- W2025442007 hasConcept C2778186239 @default.
- W2025442007 hasConcept C2778375690 @default.
- W2025442007 hasConcept C2779253243 @default.
- W2025442007 hasConcept C2779384505 @default.
- W2025442007 hasConcept C2781413609 @default.
- W2025442007 hasConcept C42219234 @default.
- W2025442007 hasConcept C71924100 @default.
- W2025442007 hasConceptScore W2025442007C118552586 @default.
- W2025442007 hasConceptScore W2025442007C126322002 @default.
- W2025442007 hasConceptScore W2025442007C142724271 @default.
- W2025442007 hasConceptScore W2025442007C197934379 @default.
- W2025442007 hasConceptScore W2025442007C204787440 @default.
- W2025442007 hasConceptScore W2025442007C2775858608 @default.
- W2025442007 hasConceptScore W2025442007C2776608144 @default.
- W2025442007 hasConceptScore W2025442007C2777288759 @default.
- W2025442007 hasConceptScore W2025442007C2778186239 @default.
- W2025442007 hasConceptScore W2025442007C2778375690 @default.
- W2025442007 hasConceptScore W2025442007C2779253243 @default.
- W2025442007 hasConceptScore W2025442007C2779384505 @default.
- W2025442007 hasConceptScore W2025442007C2781413609 @default.
- W2025442007 hasConceptScore W2025442007C42219234 @default.
- W2025442007 hasConceptScore W2025442007C71924100 @default.
- W2025442007 hasIssue "5" @default.
- W2025442007 hasLocation W20254420071 @default.
- W2025442007 hasLocation W20254420072 @default.
- W2025442007 hasOpenAccess W2025442007 @default.
- W2025442007 hasPrimaryLocation W20254420071 @default.
- W2025442007 hasRelatedWork W1983829988 @default.
- W2025442007 hasRelatedWork W2025442007 @default.
- W2025442007 hasRelatedWork W2065429157 @default.
- W2025442007 hasRelatedWork W2080867598 @default.
- W2025442007 hasRelatedWork W2081887464 @default.
- W2025442007 hasRelatedWork W2132259384 @default.
- W2025442007 hasRelatedWork W2285900047 @default.
- W2025442007 hasRelatedWork W4210315740 @default.
- W2025442007 hasRelatedWork W4229835840 @default.
- W2025442007 hasRelatedWork W4302366581 @default.
- W2025442007 hasVolume "17" @default.
- W2025442007 isParatext "false" @default.
- W2025442007 isRetracted "false" @default.
- W2025442007 magId "2025442007" @default.
- W2025442007 workType "article" @default.